SPDR S&P 400 Mid Cap Value (MDYV) Enters Oversold Territory
Current Market Analysis: The SPDR S&P 400 Mid Cap Value (MDYV) has an RSI reading of 27.6, indicating potential exhaustion from heavy selling, while the S&P 500's RSI is at 42.9.
Stock Performance Overview: MDYV's shares are currently trading at $79.52, down 1.1% for the day, with a 52-week range between $69.88 and $87.81.
Trade with 70% Backtested Accuracy
Analyst Views on MDYV
About the author
Mid-Cap ETFs Experience Strong Momentum: Is Further Growth on the Horizon?
Mid-Cap Investing Appeal: Mid-cap stocks offer a balance of resilience and growth potential, currently showing strong performance with many ETFs reaching 52-week highs, despite the risks compared to large and small caps.
Global Economic Outlook: The IMF projects a decline in global growth rates, with developed economies growing slowly, which may lead investors to be cautious about large-cap stocks due to their foreign exposure.
Federal Reserve Actions: The Fed has implemented three rate cuts this year, with projections indicating a controlled outlook for GDP growth and unemployment rates, favoring domestically-focused stocks like small and mid-caps.
Mid-Cap ETFs Performance: Several mid-cap ETFs have outperformed the SPDR S&P 500 ETF Trust recently, with notable gains over the past month, suggesting a favorable investment opportunity in this segment.
Putting It All Together: MDYV May Have a Value of $94
ETF Target Price Analysis: The SPDR S&P 400 Mid Cap Value ETF (MDYV) has an implied analyst target price of $94.24, indicating a potential upside of 12.22% from its current trading price of $83.97.
Notable Holdings with Upside: Key underlying holdings such as BioMarin Pharmaceutical (BMRN), Darling Ingredients (DAR), and Perrigo Company (PRGO) show significant upside potential, with target prices suggesting increases of 75.94%, 60.77%, and 59.92% respectively from their recent trading prices.
Analysts Predict 12% Growth Potential for MDYV
ETF Analysis: The SPDR S&P 400 Mid Cap Value ETF (MDYV) has an implied analyst target price of $93.71, indicating an 11.66% upside from its current trading price of $83.93.
Notable Holdings: Key underlying holdings with significant upside potential include Insperity Inc (NSP), New Jersey Resources Corp (NJR), and CubeSmart (CUBE), each showing expected price increases based on analyst targets.
Breaking Down the Components: MDYV May Have a Value of $93
ETF Analysis: The SPDR S&P 400 Mid Cap Value ETF (MDYV) has an implied analyst target price of $92.81, indicating an 11.21% upside from its current trading price of $83.45.
Notable Holdings: Key underlying holdings with significant upside potential include Synaptics Inc (SYNA), Crane NXT Co (CXT), and Boston Beer Co Inc (SAM), with expected increases of 18.62%, 16.27%, and 15.83% respectively.
Analyst Target Justification: There are questions regarding whether analysts' target prices are justified or overly optimistic, considering recent company and industry developments.
Investor Research Needed: Investors are encouraged to conduct further research to assess the validity of these analyst targets and their implications for future stock performance.
Analysts Anticipate MDYV Will Reach $93
ETF Analyst Target Prices: The SPDR S&P 400 Mid Cap Value ETF (MDYV) has an implied analyst target price of $92.56, indicating a potential upside of 16.42% from its current trading price of $79.50. Notable underlying holdings with significant upside include KBR Inc, Independence Realty Trust Inc, and Flowserve Corp.
Investor Research Considerations: Analysts' target prices may reflect optimism or could be outdated based on recent developments; further research is necessary to determine the validity of these targets and whether they might lead to downgrades in the future.
MDYV's Underlying Holdings Imply 10% Gain Potential
ETF Target Price Analysis: The SPDR S&P 400 Mid Cap Value ETF (MDYV) has an implied analyst target price of $90.43, indicating a potential upside of 9.89% from its current trading price of $82.29. Notable underlying holdings with significant upside include Under Armour Inc, Gentex Corp., and Flowserve Corp.
Investor Research Considerations: Analysts' target prices may reflect optimism or could be outdated based on recent developments; investors are encouraged to conduct further research to assess the validity of these targets.
Mid-Cap ETFs Experience Strong Momentum: Is Further Growth on the Horizon?
Mid-Cap Investing Appeal: Mid-cap stocks offer a balance of resilience and growth potential, currently showing strong performance with many ETFs reaching 52-week highs, despite the risks compared to large and small caps.
Global Economic Outlook: The IMF projects a decline in global growth rates, with developed economies growing slowly, which may lead investors to be cautious about large-cap stocks due to their foreign exposure.
Federal Reserve Actions: The Fed has implemented three rate cuts this year, with projections indicating a controlled outlook for GDP growth and unemployment rates, favoring domestically-focused stocks like small and mid-caps.
Mid-Cap ETFs Performance: Several mid-cap ETFs have outperformed the SPDR S&P 500 ETF Trust recently, with notable gains over the past month, suggesting a favorable investment opportunity in this segment.
Putting It All Together: MDYV May Have a Value of $94
ETF Target Price Analysis: The SPDR S&P 400 Mid Cap Value ETF (MDYV) has an implied analyst target price of $94.24, indicating a potential upside of 12.22% from its current trading price of $83.97.
Notable Holdings with Upside: Key underlying holdings such as BioMarin Pharmaceutical (BMRN), Darling Ingredients (DAR), and Perrigo Company (PRGO) show significant upside potential, with target prices suggesting increases of 75.94%, 60.77%, and 59.92% respectively from their recent trading prices.
Analysts Predict 12% Growth Potential for MDYV
ETF Analysis: The SPDR S&P 400 Mid Cap Value ETF (MDYV) has an implied analyst target price of $93.71, indicating an 11.66% upside from its current trading price of $83.93.
Notable Holdings: Key underlying holdings with significant upside potential include Insperity Inc (NSP), New Jersey Resources Corp (NJR), and CubeSmart (CUBE), each showing expected price increases based on analyst targets.
Breaking Down the Components: MDYV May Have a Value of $93
ETF Analysis: The SPDR S&P 400 Mid Cap Value ETF (MDYV) has an implied analyst target price of $92.81, indicating an 11.21% upside from its current trading price of $83.45.
Notable Holdings: Key underlying holdings with significant upside potential include Synaptics Inc (SYNA), Crane NXT Co (CXT), and Boston Beer Co Inc (SAM), with expected increases of 18.62%, 16.27%, and 15.83% respectively.
Analyst Target Justification: There are questions regarding whether analysts' target prices are justified or overly optimistic, considering recent company and industry developments.
Investor Research Needed: Investors are encouraged to conduct further research to assess the validity of these analyst targets and their implications for future stock performance.
Analysts Anticipate MDYV Will Reach $93
ETF Analyst Target Prices: The SPDR S&P 400 Mid Cap Value ETF (MDYV) has an implied analyst target price of $92.56, indicating a potential upside of 16.42% from its current trading price of $79.50. Notable underlying holdings with significant upside include KBR Inc, Independence Realty Trust Inc, and Flowserve Corp.
Investor Research Considerations: Analysts' target prices may reflect optimism or could be outdated based on recent developments; further research is necessary to determine the validity of these targets and whether they might lead to downgrades in the future.
MDYV's Underlying Holdings Imply 10% Gain Potential
ETF Target Price Analysis: The SPDR S&P 400 Mid Cap Value ETF (MDYV) has an implied analyst target price of $90.43, indicating a potential upside of 9.89% from its current trading price of $82.29. Notable underlying holdings with significant upside include Under Armour Inc, Gentex Corp., and Flowserve Corp.
Investor Research Considerations: Analysts' target prices may reflect optimism or could be outdated based on recent developments; investors are encouraged to conduct further research to assess the validity of these targets.
